Median time to progression after tamoxifen chemotherapy between GBM vs. non-GBM patients.

Table 2: Median time to progression after tamoxifen chemotherapy between GBM vs. non-GBM patients.

Response	Median time to progression in weeks (%)
Response	Non-GBM n = 86	p-value	GBM n = 81	p-value
Progressive disease	9.7 (79.8)	< 0.001	8.5 (83.1)	0.002
Stable disease	34.4 (17.7)	< 0.001	23.6 (14.3)	0.002
Partial response	147.7 (2.5)	< 0.001	49.8 (2.6)	< 0.001

The p-value compares those with progressive disease versus those with stable disease and progressive disease versus those with partial response.